Legal Opinion
Astellas Pharma Inc. v. Sandoz Inc.
District Court, D. Delaware
Decided May 30, 2025No. 1:20-cv-01589Unknown
1Opinion
IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE ASTELLAS PHARMA INC., et al. Plaintiffs, 1:20CV1589 v. MEMORANDUM AND ORDER ZYDUS, INC., et. al. Defendants. This matter is before the Court on the Generics Manufacturers1 Motion for Relief from Stipulation.2 D.I. 732. This is a consolidated patent infringement case involving several patents covering the overactive bladder drug Myrbetriq® set for trial in early 2026. The parties’ current dispute involves one of these patents—United States Patent No. 10,842,780 (“‘780 Patent”). The validity of the ‘780 Patent was previously tried…
2Cases cited4 opinions
- Wordtech Systems, Inc. v. Integrated Networks Solutions, Inc.Court of Appeals for the Federal Circuit · 2010
- TecSec, Inc. v. International Business MacHines Corp.Court of Appeals for the Federal Circuit · 2013
- Waldorf v. ShutaCourt of Appeals for the Third Circuit · 1998
- Astellas Pharma, Inc. v. Sandoz Inc.Court of Appeals for the Federal Circuit · 2024